In most types of cancer, two immune checkpoints, programmed cell death protein 1 (PD-1) (91, 92) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) (93, 94), were observed with an upregulated expression on T cells in the TME. This evidence concerns the gene PDCD1 and cancer.